Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duowell vs Telmisartan for Central Aortic Pressure in Hypertension with Dyslipidemia
NCT03267329Phase 4Completed
- Sponsor
- Yuhan
- Start
- Sep 2017
- Primary completion
- Sep 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan + rosuvastatin in hypertension (HTN), dyslipidemia, sponsored by Yuhan. Started Sep 2017; status: completed.
02
Drugs
telmisartan + rosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT03267329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03267329.